Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
6.73
-0.21 (-3.03%)
Mar 27, 2026, 4:00 PM EDT - Market closed
Fulcrum Therapeutics Market Cap
Fulcrum Therapeutics has a market cap or net worth of $448.22 million as of March 27, 2026. Its market cap has increased by 186.33% in one year.
Market Cap
448.22M
Enterprise Value
102.36M
1-Year Change
186.33%
Ranking
Category
Stock Price
$6.73
Market Cap Chart
Since July 18, 2019, Fulcrum Therapeutics's market cap has increased from $301.64M to $448.22M, an increase of 48.59%. That is a compound annual growth rate of 6.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 448.22M | -39.93% |
| Dec 31, 2025 | 746.12M | 194.32% |
| Dec 31, 2024 | 253.51M | -39.25% |
| Dec 29, 2023 | 417.30M | 10.13% |
| Dec 30, 2022 | 378.93M | -47.15% |
| Dec 31, 2021 | 716.95M | 124.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Larimar Therapeutics | 486.17M |
| Rigel Pharmaceuticals | 485.66M |
| enGene Holdings | 473.62M |
| Immix Biopharma | 471.91M |
| Lyell Immunopharma | 469.41M |
| Entrada Therapeutics | 461.33M |
| Shattuck Labs | 455.86M |
| Maravai LifeSciences Holdings | 455.25M |